id	sid	tid	token	lemma	pos
cord-285428-fcrunf38	1	1	key	key	NN
cord-285428-fcrunf38	1	2	:	:	:
cord-285428-fcrunf38	1	3	cord-285428-fcrunf38	cord-285428-fcrunf38	``
cord-285428-fcrunf38	1	4	authors	author	NNS
cord-285428-fcrunf38	1	5	:	:	:
cord-285428-fcrunf38	1	6	Halstead	Halstead	NNP
cord-285428-fcrunf38	1	7	,	,	,
cord-285428-fcrunf38	1	8	Scott	Scott	NNP
cord-285428-fcrunf38	1	9	B.	B.	NNP
cord-285428-fcrunf38	1	10	title	title	NN
cord-285428-fcrunf38	1	11	:	:	:
cord-285428-fcrunf38	2	1	COVID-19	covid-19	VB
cord-285428-fcrunf38	2	2	:	:	:
cord-285428-fcrunf38	2	3	The	the	DT
cord-285428-fcrunf38	2	4	Need	need	NN
cord-285428-fcrunf38	2	5	for	for	IN
cord-285428-fcrunf38	2	6	Immunoprevention	Immunoprevention	NNP
cord-285428-fcrunf38	2	7	at	at	IN
cord-285428-fcrunf38	2	8	Industrial	Industrial	NNP
cord-285428-fcrunf38	2	9	Scale	Scale	NNP
cord-285428-fcrunf38	2	10	date	date	NN
cord-285428-fcrunf38	2	11	:	:	:
cord-285428-fcrunf38	2	12	2020	2020	CD
cord-285428-fcrunf38	2	13	-	-	HYPH
cord-285428-fcrunf38	2	14	04	04	CD
cord-285428-fcrunf38	2	15	-	-	HYPH
cord-285428-fcrunf38	2	16	08	08	CD
cord-285428-fcrunf38	2	17	journal	journal	NN
cord-285428-fcrunf38	2	18	:	:	:
cord-285428-fcrunf38	3	1	Am	be	VBP
cord-285428-fcrunf38	3	2	J	J	NNP
cord-285428-fcrunf38	3	3	Trop	Trop	NNP
cord-285428-fcrunf38	3	4	Med	Med	NNP
cord-285428-fcrunf38	3	5	Hyg	Hyg	NNP
cord-285428-fcrunf38	3	6	DOI	doi	NN
cord-285428-fcrunf38	3	7	:	:	:
cord-285428-fcrunf38	4	1	10.4269	10.4269	CD
cord-285428-fcrunf38	4	2	/	/	SYM
cord-285428-fcrunf38	4	3	ajtmh.20	ajtmh.20	NNP
cord-285428-fcrunf38	4	4	-	-	HYPH
cord-285428-fcrunf38	4	5	0239	0239	CD
cord-285428-fcrunf38	4	6	sha	sha	NNP
cord-285428-fcrunf38	5	1	:	:	:
cord-285428-fcrunf38	5	2	fb6dbe8d9cc1d6789aaea7e6800e7fefda749134	fb6dbe8d9cc1d6789aaea7e6800e7fefda749134	NNP
cord-285428-fcrunf38	5	3	doc_id	doc_id	NNPS
cord-285428-fcrunf38	5	4	:	:	:
cord-285428-fcrunf38	5	5	285428	285428	CD
cord-285428-fcrunf38	5	6	cord_uid	cord_uid	NNS
cord-285428-fcrunf38	5	7	:	:	:
cord-285428-fcrunf38	6	1	fcrunf38	fcrunf38	NNP
cord-285428-fcrunf38	7	1	Novel	Novel	NNP
cord-285428-fcrunf38	7	2	Coronavirus	Coronavirus	NNP
cord-285428-fcrunf38	7	3	Disease	Disease	NNP
cord-285428-fcrunf38	7	4	(	(	-LRB-
cord-285428-fcrunf38	7	5	COVID-19	COVID-19	NNP
cord-285428-fcrunf38	7	6	)	)	-RRB-
cord-285428-fcrunf38	7	7	:	:	:
cord-285428-fcrunf38	8	1	The	the	DT
cord-285428-fcrunf38	8	2	Need	need	NN
cord-285428-fcrunf38	8	3	for	for	IN
cord-285428-fcrunf38	8	4	Immunoprevention	Immunoprevention	NNP
cord-285428-fcrunf38	8	5	at	at	IN
cord-285428-fcrunf38	8	6	Industrial	Industrial	NNP
cord-285428-fcrunf38	8	7	Scale	Scale	NNP
cord-285428-fcrunf38	8	8	.	.	.
cord-285428-fcrunf38	9	1	Severe	severe	JJ
cord-285428-fcrunf38	9	2	acute	acute	JJ
cord-285428-fcrunf38	9	3	respiratory	respiratory	JJ
cord-285428-fcrunf38	9	4	syndrome	syndrome	NN
cord-285428-fcrunf38	9	5	-	-	:
cord-285428-fcrunf38	9	6	CoV-2	CoV-2	NNP
cord-285428-fcrunf38	9	7	infections	infection	NNS
cord-285428-fcrunf38	9	8	are	be	VBP
cord-285428-fcrunf38	9	9	exacting	exact	VBG
cord-285428-fcrunf38	9	10	devastating	devastating	JJ
cord-285428-fcrunf38	9	11	mortality	mortality	NN
cord-285428-fcrunf38	9	12	in	in	IN
cord-285428-fcrunf38	9	13	elderly	elderly	JJ
cord-285428-fcrunf38	9	14	persons	person	NNS
cord-285428-fcrunf38	9	15	with	with	IN
cord-285428-fcrunf38	9	16	preexisting	preexist	VBG
cord-285428-fcrunf38	9	17	health	health	NN
cord-285428-fcrunf38	9	18	conditions	condition	NNS
cord-285428-fcrunf38	9	19	.	.	.
cord-285428-fcrunf38	10	1	This	this	DT
cord-285428-fcrunf38	10	2	has	have	VBZ
cord-285428-fcrunf38	10	3	led	lead	VBN
cord-285428-fcrunf38	10	4	to	to	IN
cord-285428-fcrunf38	10	5	widespread	widespread	JJ
cord-285428-fcrunf38	10	6	quarantining	quarantining	NN
cord-285428-fcrunf38	10	7	,	,	,
cord-285428-fcrunf38	10	8	suspension	suspension	NN
cord-285428-fcrunf38	10	9	of	of	IN
cord-285428-fcrunf38	10	10	social	social	JJ
cord-285428-fcrunf38	10	11	and	and	CC
cord-285428-fcrunf38	10	12	business	business	NN
cord-285428-fcrunf38	10	13	activities	activity	NNS
cord-285428-fcrunf38	10	14	,	,	,
cord-285428-fcrunf38	10	15	frightening	frightening	JJ
cord-285428-fcrunf38	10	16	levels	level	NNS
cord-285428-fcrunf38	10	17	of	of	IN
cord-285428-fcrunf38	10	18	morbidity	morbidity	NN
cord-285428-fcrunf38	10	19	and	and	CC
cord-285428-fcrunf38	10	20	mortality	mortality	NN
cord-285428-fcrunf38	10	21	,	,	,
cord-285428-fcrunf38	10	22	and	and	CC
cord-285428-fcrunf38	10	23	enormous	enormous	JJ
cord-285428-fcrunf38	10	24	economic	economic	JJ
cord-285428-fcrunf38	10	25	loss	loss	NN
cord-285428-fcrunf38	10	26	.	.	.
cord-285428-fcrunf38	11	1	As	as	IN
cord-285428-fcrunf38	11	2	in	in	IN
cord-285428-fcrunf38	11	3	the	the	DT
cord-285428-fcrunf38	11	4	past	past	NN
cord-285428-fcrunf38	11	5	,	,	,
cord-285428-fcrunf38	11	6	the	the	DT
cord-285428-fcrunf38	11	7	nation	nation	NN
cord-285428-fcrunf38	11	8	has	have	VBZ
cord-285428-fcrunf38	11	9	quickly	quickly	RB
cord-285428-fcrunf38	11	10	found	find	VBN
cord-285428-fcrunf38	11	11	technical	technical	JJ
cord-285428-fcrunf38	11	12	solutions	solution	NNS
cord-285428-fcrunf38	11	13	to	to	TO
cord-285428-fcrunf38	11	14	cope	cope	VB
cord-285428-fcrunf38	11	15	with	with	IN
cord-285428-fcrunf38	11	16	this	this	DT
cord-285428-fcrunf38	11	17	challenge	challenge	NN
cord-285428-fcrunf38	11	18	.	.	.
cord-285428-fcrunf38	12	1	Industry	industry	NN
cord-285428-fcrunf38	12	2	has	have	VBZ
cord-285428-fcrunf38	12	3	rapidly	rapidly	RB
cord-285428-fcrunf38	12	4	provided	provide	VBN
cord-285428-fcrunf38	12	5	improved	improved	JJ
cord-285428-fcrunf38	12	6	tests	test	NNS
cord-285428-fcrunf38	12	7	to	to	TO
cord-285428-fcrunf38	12	8	detect	detect	VB
cord-285428-fcrunf38	12	9	viral	viral	JJ
cord-285428-fcrunf38	12	10	RNA	rna	NN
cord-285428-fcrunf38	12	11	,	,	,
cord-285428-fcrunf38	12	12	respirator	respirator	NN
cord-285428-fcrunf38	12	13	masks	mask	NNS
cord-285428-fcrunf38	12	14	to	to	TO
cord-285428-fcrunf38	12	15	prevent	prevent	VB
cord-285428-fcrunf38	12	16	infections	infection	NNS
cord-285428-fcrunf38	12	17	,	,	,
cord-285428-fcrunf38	12	18	and	and	CC
cord-285428-fcrunf38	12	19	ventilators	ventilator	NNS
cord-285428-fcrunf38	12	20	for	for	IN
cord-285428-fcrunf38	12	21	critical	critical	JJ
cord-285428-fcrunf38	12	22	intensive	intensive	JJ
cord-285428-fcrunf38	12	23	care	care	NN
cord-285428-fcrunf38	12	24	;	;	:
cord-285428-fcrunf38	12	25	however	however	RB
cord-285428-fcrunf38	12	26	,	,	,
cord-285428-fcrunf38	12	27	due	due	IN
cord-285428-fcrunf38	12	28	to	to	IN
cord-285428-fcrunf38	12	29	the	the	DT
cord-285428-fcrunf38	12	30	scale	scale	NN
cord-285428-fcrunf38	12	31	of	of	IN
cord-285428-fcrunf38	12	32	the	the	DT
cord-285428-fcrunf38	12	33	pandemic	pandemic	NN
cord-285428-fcrunf38	12	34	,	,	,
cord-285428-fcrunf38	12	35	large	large	JJ
cord-285428-fcrunf38	12	36	needs	need	NNS
cord-285428-fcrunf38	12	37	remain	remain	VBP
cord-285428-fcrunf38	12	38	.	.	.
cord-285428-fcrunf38	13	1	These	these	DT
cord-285428-fcrunf38	13	2	and	and	CC
cord-285428-fcrunf38	13	3	other	other	JJ
cord-285428-fcrunf38	13	4	requirements	requirement	NNS
cord-285428-fcrunf38	13	5	identified	identify	VBN
cord-285428-fcrunf38	13	6	by	by	IN
cord-285428-fcrunf38	13	7	the	the	DT
cord-285428-fcrunf38	13	8	U.S.	U.S.	NNP
cord-285428-fcrunf38	13	9	coronavirus	coronavirus	NN
cord-285428-fcrunf38	13	10	task	task	NN
cord-285428-fcrunf38	13	11	force	force	NN
cord-285428-fcrunf38	13	12	have	have	VBP
cord-285428-fcrunf38	13	13	come	come	VBN
cord-285428-fcrunf38	13	14	from	from	IN
cord-285428-fcrunf38	13	15	rapid	rapid	JJ
cord-285428-fcrunf38	13	16	and	and	CC
cord-285428-fcrunf38	13	17	generous	generous	JJ
cord-285428-fcrunf38	13	18	responses	response	NNS
cord-285428-fcrunf38	13	19	by	by	IN
cord-285428-fcrunf38	13	20	industry	industry	NN
cord-285428-fcrunf38	13	21	.	.	.
cord-285428-fcrunf38	14	1	Can	Can	MD
cord-285428-fcrunf38	14	2	we	-PRON-	PRP
cord-285428-fcrunf38	14	3	prevent	prevent	VB
cord-285428-fcrunf38	14	4	these	these	DT
cord-285428-fcrunf38	14	5	deaths	death	NNS
cord-285428-fcrunf38	14	6	?	?	.
cord-285428-fcrunf38	15	1	Vaccines	vaccine	NNS
cord-285428-fcrunf38	15	2	,	,	,
cord-285428-fcrunf38	15	3	antiviral	antiviral	JJ
cord-285428-fcrunf38	15	4	drugs	drug	NNS
cord-285428-fcrunf38	15	5	,	,	,
cord-285428-fcrunf38	15	6	and	and	CC
cord-285428-fcrunf38	15	7	antibodies	antibody	NNS
cord-285428-fcrunf38	15	8	are	be	VBP
cord-285428-fcrunf38	15	9	our	-PRON-	PRP$
cord-285428-fcrunf38	15	10	tools	tool	NNS
cord-285428-fcrunf38	15	11	of	of	IN
cord-285428-fcrunf38	15	12	choice	choice	NN
cord-285428-fcrunf38	15	13	.	.	.
cord-285428-fcrunf38	16	1	The	the	DT
cord-285428-fcrunf38	16	2	best	good	JJS
cord-285428-fcrunf38	16	3	option	option	NN
cord-285428-fcrunf38	16	4	would	would	MD
cord-285428-fcrunf38	16	5	be	be	VB
cord-285428-fcrunf38	16	6	a	a	DT
cord-285428-fcrunf38	16	7	single	single	JJ
cord-285428-fcrunf38	16	8	-	-	HYPH
cord-285428-fcrunf38	16	9	dose	dose	NN
cord-285428-fcrunf38	16	10	vaccine	vaccine	NN
cord-285428-fcrunf38	16	11	.	.	.
cord-285428-fcrunf38	17	1	Efforts	effort	NNS
cord-285428-fcrunf38	17	2	to	to	TO
cord-285428-fcrunf38	17	3	develop	develop	VB
cord-285428-fcrunf38	17	4	vaccines	vaccine	NNS
cord-285428-fcrunf38	17	5	against	against	IN
cord-285428-fcrunf38	17	6	Coronavirus	Coronavirus	NNP
cord-285428-fcrunf38	17	7	disease-19	disease-19	,
cord-285428-fcrunf38	17	8	(	(	-LRB-
cord-285428-fcrunf38	17	9	COVID-19	COVID-19	NNP
cord-285428-fcrunf38	17	10	)	)	-RRB-
cord-285428-fcrunf38	17	11	are	be	VBP
cord-285428-fcrunf38	17	12	well	well	RB
cord-285428-fcrunf38	17	13	advanced	advanced	JJ
cord-285428-fcrunf38	17	14	,	,	,
cord-285428-fcrunf38	17	15	based	base	VBN
cord-285428-fcrunf38	17	16	in	in	IN
cord-285428-fcrunf38	17	17	part	part	NN
cord-285428-fcrunf38	17	18	on	on	IN
cord-285428-fcrunf38	17	19	experience	experience	NN
cord-285428-fcrunf38	17	20	with	with	IN
cord-285428-fcrunf38	17	21	severe	severe	JJ
cord-285428-fcrunf38	17	22	acute	acute	JJ
cord-285428-fcrunf38	17	23	respiratory	respiratory	JJ
cord-285428-fcrunf38	17	24	syndrome	syndrome	NN
cord-285428-fcrunf38	17	25	(	(	-LRB-
cord-285428-fcrunf38	17	26	SARS	SARS	NNP
cord-285428-fcrunf38	17	27	)	)	-RRB-
cord-285428-fcrunf38	17	28	and	and	CC
cord-285428-fcrunf38	17	29	Middle	Middle	NNP
cord-285428-fcrunf38	17	30	East	East	NNP
cord-285428-fcrunf38	17	31	respiratory	respiratory	JJ
cord-285428-fcrunf38	17	32	syndrome	syndrome	NN
cord-285428-fcrunf38	17	33	(	(	-LRB-
cord-285428-fcrunf38	17	34	MERS	MERS	NNP
cord-285428-fcrunf38	17	35	)	)	-RRB-
cord-285428-fcrunf38	17	36	.	.	.
cord-285428-fcrunf38	18	1	1	1	LS
cord-285428-fcrunf38	19	1	However	however	RB
cord-285428-fcrunf38	19	2	,	,	,
cord-285428-fcrunf38	19	3	before	before	IN
cord-285428-fcrunf38	19	4	release	release	NN
cord-285428-fcrunf38	19	5	,	,	,
cord-285428-fcrunf38	19	6	vaccines	vaccine	NNS
cord-285428-fcrunf38	19	7	must	must	MD
cord-285428-fcrunf38	19	8	demonstrate	demonstrate	VB
cord-285428-fcrunf38	19	9	relevant	relevant	JJ
cord-285428-fcrunf38	19	10	immune	immune	JJ
cord-285428-fcrunf38	19	11	responses	response	NNS
cord-285428-fcrunf38	19	12	in	in	IN
cord-285428-fcrunf38	19	13	human	human	JJ
cord-285428-fcrunf38	19	14	volunteers	volunteer	NNS
cord-285428-fcrunf38	19	15	,	,	,
cord-285428-fcrunf38	19	16	absence	absence	NN
cord-285428-fcrunf38	19	17	of	of	IN
cord-285428-fcrunf38	19	18	unwanted	unwanted	JJ
cord-285428-fcrunf38	19	19	side	side	NN
cord-285428-fcrunf38	19	20	effects	effect	NNS
cord-285428-fcrunf38	19	21	,	,	,
cord-285428-fcrunf38	19	22	and	and	CC
cord-285428-fcrunf38	19	23	protection	protection	NN
cord-285428-fcrunf38	19	24	of	of	IN
cord-285428-fcrunf38	19	25	humans	human	NNS
cord-285428-fcrunf38	19	26	from	from	IN
cord-285428-fcrunf38	19	27	disease	disease	NN
cord-285428-fcrunf38	19	28	.	.	.
cord-285428-fcrunf38	20	1	These	these	DT
cord-285428-fcrunf38	20	2	steps	step	NNS
cord-285428-fcrunf38	20	3	take	take	VBP
cord-285428-fcrunf38	20	4	many	many	JJ
cord-285428-fcrunf38	20	5	months	month	NNS
cord-285428-fcrunf38	20	6	to	to	TO
cord-285428-fcrunf38	20	7	complete	complete	VB
cord-285428-fcrunf38	20	8	.	.	.
cord-285428-fcrunf38	21	1	Antivirals	antiviral	NNS
cord-285428-fcrunf38	21	2	have	have	VBP
cord-285428-fcrunf38	21	3	already	already	RB
cord-285428-fcrunf38	21	4	achieved	achieve	VBN
cord-285428-fcrunf38	21	5	wide	wide	JJ
cord-285428-fcrunf38	21	6	attention	attention	NN
cord-285428-fcrunf38	21	7	.	.	.
cord-285428-fcrunf38	22	1	A	a	DT
cord-285428-fcrunf38	22	2	near	near	JJ
cord-285428-fcrunf38	22	3	-	-	HYPH
cord-285428-fcrunf38	22	4	term	term	NN
cord-285428-fcrunf38	22	5	solution	solution	NN
cord-285428-fcrunf38	22	6	is	be	VBZ
cord-285428-fcrunf38	22	7	to	to	TO
cord-285428-fcrunf38	22	8	repurpose	repurpose	VB
cord-285428-fcrunf38	22	9	existing	existing	JJ
cord-285428-fcrunf38	22	10	drugs	drug	NNS
cord-285428-fcrunf38	22	11	.	.	.
cord-285428-fcrunf38	23	1	Remdesivir	Remdesivir	NNP
cord-285428-fcrunf38	23	2	,	,	,
cord-285428-fcrunf38	23	3	a	a	DT
cord-285428-fcrunf38	23	4	nucleotide	nucleotide	JJ
cord-285428-fcrunf38	23	5	analog	analog	NN
cord-285428-fcrunf38	23	6	,	,	,
cord-285428-fcrunf38	23	7	is	be	VBZ
cord-285428-fcrunf38	23	8	under	under	IN
cord-285428-fcrunf38	23	9	clinical	clinical	JJ
cord-285428-fcrunf38	23	10	investigation	investigation	NN
cord-285428-fcrunf38	23	11	in	in	IN
cord-285428-fcrunf38	23	12	China	China	NNP
cord-285428-fcrunf38	23	13	and	and	CC
cord-285428-fcrunf38	23	14	elsewhere	elsewhere	RB
cord-285428-fcrunf38	23	15	.	.	.
cord-285428-fcrunf38	24	1	This	this	DT
cord-285428-fcrunf38	24	2	drug	drug	NN
cord-285428-fcrunf38	24	3	has	have	VBZ
cord-285428-fcrunf38	24	4	shown	show	VBN
cord-285428-fcrunf38	24	5	efficacy	efficacy	NN
cord-285428-fcrunf38	24	6	against	against	IN
cord-285428-fcrunf38	24	7	MERS	MERS	NNP
cord-285428-fcrunf38	24	8	disease	disease	NN
cord-285428-fcrunf38	24	9	in	in	IN
cord-285428-fcrunf38	24	10	a	a	DT
cord-285428-fcrunf38	24	11	monkey	monkey	NN
cord-285428-fcrunf38	24	12	model	model	NN
cord-285428-fcrunf38	24	13	.	.	.
cord-285428-fcrunf38	25	1	2	2	LS
cord-285428-fcrunf38	25	2	Antibodies	antibody	NNS
cord-285428-fcrunf38	25	3	from	from	IN
cord-285428-fcrunf38	25	4	convalescents	convalescent	NNS
cord-285428-fcrunf38	25	5	or	or	CC
cord-285428-fcrunf38	25	6	monoclonal	monoclonal	JJ
cord-285428-fcrunf38	25	7	antibodies	antibody	NNS
cord-285428-fcrunf38	25	8	derived	derive	VBN
cord-285428-fcrunf38	25	9	from	from	IN
cord-285428-fcrunf38	25	10	immunes	immune	NNS
cord-285428-fcrunf38	25	11	,	,	,
cord-285428-fcrunf38	25	12	given	give	VBN
cord-285428-fcrunf38	25	13	early	early	RB
cord-285428-fcrunf38	25	14	in	in	IN
cord-285428-fcrunf38	25	15	illness	illness	NN
cord-285428-fcrunf38	25	16	,	,	,
cord-285428-fcrunf38	25	17	may	may	MD
cord-285428-fcrunf38	25	18	reduce	reduce	VB
cord-285428-fcrunf38	25	19	disease	disease	NN
cord-285428-fcrunf38	25	20	severity	severity	NN
cord-285428-fcrunf38	25	21	and	and	CC
cord-285428-fcrunf38	25	22	save	save	VB
cord-285428-fcrunf38	25	23	lives	life	NNS
cord-285428-fcrunf38	25	24	.	.	.
cord-285428-fcrunf38	26	1	3	3	CD
cord-285428-fcrunf38	26	2	Convalescent	Convalescent	NNP
cord-285428-fcrunf38	26	3	SARS	SARS	NNP
cord-285428-fcrunf38	26	4	antibodies	antibody	NNS
cord-285428-fcrunf38	26	5	given	give	VBN
cord-285428-fcrunf38	26	6	early	early	RB
cord-285428-fcrunf38	26	7	in	in	IN
cord-285428-fcrunf38	26	8	illness	illness	NN
cord-285428-fcrunf38	26	9	have	have	VBP
cord-285428-fcrunf38	26	10	been	be	VBN
cord-285428-fcrunf38	26	11	shown	show	VBN
cord-285428-fcrunf38	26	12	to	to	TO
cord-285428-fcrunf38	26	13	reduce	reduce	VB
cord-285428-fcrunf38	26	14	disease	disease	NN
cord-285428-fcrunf38	26	15	severity	severity	NN
cord-285428-fcrunf38	26	16	.	.	.
cord-285428-fcrunf38	27	1	4	4	LS
cord-285428-fcrunf38	28	1	In	in	IN
cord-285428-fcrunf38	28	2	addition	addition	NN
cord-285428-fcrunf38	28	3	,	,	,
cord-285428-fcrunf38	28	4	it	-PRON-	PRP
cord-285428-fcrunf38	28	5	is	be	VBZ
cord-285428-fcrunf38	28	6	likely	likely	JJ
cord-285428-fcrunf38	28	7	that	that	IN
cord-285428-fcrunf38	28	8	entirely	entirely	RB
cord-285428-fcrunf38	28	9	new	new	JJ
cord-285428-fcrunf38	28	10	useful	useful	JJ
cord-285428-fcrunf38	28	11	compounds	compound	NNS
cord-285428-fcrunf38	28	12	will	will	MD
cord-285428-fcrunf38	28	13	emerge	emerge	VB
cord-285428-fcrunf38	28	14	from	from	IN
cord-285428-fcrunf38	28	15	the	the	DT
cord-285428-fcrunf38	28	16	laboratory	laboratory	NN
cord-285428-fcrunf38	28	17	.	.	.
cord-285428-fcrunf38	29	1	Prevention	Prevention	NNP
cord-285428-fcrunf38	29	2	of	of	IN
cord-285428-fcrunf38	29	3	COVID-19	COVID-19	NNP
cord-285428-fcrunf38	29	4	may	may	MD
cord-285428-fcrunf38	29	5	be	be	VB
cord-285428-fcrunf38	29	6	possible	possible	JJ
cord-285428-fcrunf38	29	7	using	use	VBG
cord-285428-fcrunf38	29	8	antibodies	antibody	NNS
cord-285428-fcrunf38	29	9	.	.	.
cord-285428-fcrunf38	30	1	Previously	previously	RB
cord-285428-fcrunf38	30	2	in	in	IN
cord-285428-fcrunf38	30	3	the	the	DT
cord-285428-fcrunf38	30	4	United	United	NNP
cord-285428-fcrunf38	30	5	States	States	NNP
cord-285428-fcrunf38	30	6	,	,	,
cord-285428-fcrunf38	30	7	commercial	commercial	JJ
cord-285428-fcrunf38	30	8	gamma	gamma	NN
cord-285428-fcrunf38	30	9	globulin	globulin	NN
cord-285428-fcrunf38	30	10	provided	provide	VBD
cord-285428-fcrunf38	30	11	short	short	JJ
cord-285428-fcrunf38	30	12	-	-	HYPH
cord-285428-fcrunf38	30	13	term	term	NN
cord-285428-fcrunf38	30	14	prevention	prevention	NN
cord-285428-fcrunf38	30	15	against	against	IN
cord-285428-fcrunf38	30	16	measles	measle	NNS
cord-285428-fcrunf38	30	17	,	,	,
cord-285428-fcrunf38	30	18	paralytic	paralytic	JJ
cord-285428-fcrunf38	30	19	poliomyelitis	poliomyelitis	NN
cord-285428-fcrunf38	30	20	,	,	,
cord-285428-fcrunf38	30	21	and	and	CC
cord-285428-fcrunf38	30	22	hepatitis	hepatitis	NN
cord-285428-fcrunf38	30	23	A.	a.	NN
cord-285428-fcrunf38	30	24	[	[	-LRB-
cord-285428-fcrunf38	30	25	5	5	CD
cord-285428-fcrunf38	30	26	]	]	-RRB-
cord-285428-fcrunf38	30	27	[	[	-LRB-
cord-285428-fcrunf38	30	28	6	6	CD
cord-285428-fcrunf38	30	29	]	]	-RRB-
cord-285428-fcrunf38	30	30	[	[	-LRB-
cord-285428-fcrunf38	30	31	7	7	CD
cord-285428-fcrunf38	30	32	]	]	-RRB-
cord-285428-fcrunf38	31	1	[	[	-LRB-
cord-285428-fcrunf38	31	2	8	8	CD
cord-285428-fcrunf38	31	3	]	]	-RRB-
cord-285428-fcrunf38	32	1	In	in	IN
cord-285428-fcrunf38	32	2	the	the	DT
cord-285428-fcrunf38	32	3	1950s	1950	NNS
cord-285428-fcrunf38	32	4	,	,	,
cord-285428-fcrunf38	32	5	William	William	NNP
cord-285428-fcrunf38	32	6	McD	McD	NNP
cord-285428-fcrunf38	32	7	Hammon	Hammon	NNP
cord-285428-fcrunf38	32	8	at	at	IN
cord-285428-fcrunf38	32	9	the	the	DT
cord-285428-fcrunf38	32	10	University	University	NNP
cord-285428-fcrunf38	32	11	of	of	IN
cord-285428-fcrunf38	32	12	Pittsburgh	Pittsburgh	NNP
cord-285428-fcrunf38	32	13	demonstrated	demonstrate	VBD
cord-285428-fcrunf38	32	14	that	that	IN
cord-285428-fcrunf38	32	15	gamma	gamma	NN
cord-285428-fcrunf38	32	16	globulin	globulin	NN
cord-285428-fcrunf38	32	17	given	give	VBN
cord-285428-fcrunf38	32	18	to	to	IN
cord-285428-fcrunf38	32	19	100,000	100,000	CD
cord-285428-fcrunf38	32	20	children	child	NNS
cord-285428-fcrunf38	32	21	in	in	IN
cord-285428-fcrunf38	32	22	a	a	DT
cord-285428-fcrunf38	32	23	blinded	blinded	JJ
cord-285428-fcrunf38	32	24	efficacy	efficacy	NN
cord-285428-fcrunf38	32	25	trial	trial	NN
cord-285428-fcrunf38	32	26	successfully	successfully	RB
cord-285428-fcrunf38	32	27	blunted	blunt	VBD
cord-285428-fcrunf38	32	28	paralysis	paralysis	NN
cord-285428-fcrunf38	32	29	attack	attack	NN
cord-285428-fcrunf38	32	30	rates	rate	NNS
cord-285428-fcrunf38	32	31	during	during	IN
cord-285428-fcrunf38	32	32	epidemics	epidemic	NNS
cord-285428-fcrunf38	32	33	of	of	IN
cord-285428-fcrunf38	32	34	poliomyelitis	poliomyelitis	NN
cord-285428-fcrunf38	32	35	.	.	.
cord-285428-fcrunf38	33	1	7	7	CD
cord-285428-fcrunf38	33	2	Gamma	Gamma	NNP
cord-285428-fcrunf38	33	3	globulin	globulin	NN
cord-285428-fcrunf38	33	4	prepared	prepare	VBN
cord-285428-fcrunf38	33	5	from	from	IN
cord-285428-fcrunf38	33	6	immune	immune	JJ
cord-285428-fcrunf38	33	7	donors	donor	NNS
cord-285428-fcrunf38	33	8	or	or	CC
cord-285428-fcrunf38	33	9	protective	protective	JJ
cord-285428-fcrunf38	33	10	monoclonal	monoclonal	JJ
cord-285428-fcrunf38	33	11	antibodies	antibody	NNS
cord-285428-fcrunf38	33	12	offer	offer	VBP
cord-285428-fcrunf38	33	13	possibilities	possibility	NNS
cord-285428-fcrunf38	33	14	of	of	IN
cord-285428-fcrunf38	33	15	short	short	JJ
cord-285428-fcrunf38	33	16	-	-	HYPH
cord-285428-fcrunf38	33	17	term	term	NN
cord-285428-fcrunf38	33	18	protection	protection	NN
cord-285428-fcrunf38	33	19	for	for	IN
cord-285428-fcrunf38	33	20	care	care	NN
cord-285428-fcrunf38	33	21	givers	giver	NNS
cord-285428-fcrunf38	33	22	and	and	CC
cord-285428-fcrunf38	33	23	healthcare	healthcare	NN
cord-285428-fcrunf38	33	24	workers	worker	NNS
cord-285428-fcrunf38	33	25	and	and	CC
cord-285428-fcrunf38	33	26	,	,	,
cord-285428-fcrunf38	33	27	in	in	IN
cord-285428-fcrunf38	33	28	particular	particular	JJ
cord-285428-fcrunf38	33	29	,	,	,
cord-285428-fcrunf38	33	30	for	for	IN
cord-285428-fcrunf38	33	31	those	those	DT
cord-285428-fcrunf38	33	32	at	at	IN
cord-285428-fcrunf38	33	33	high	high	JJ
cord-285428-fcrunf38	33	34	risk	risk	NN
cord-285428-fcrunf38	33	35	of	of	IN
cord-285428-fcrunf38	33	36	severe	severe	JJ
cord-285428-fcrunf38	33	37	or	or	CC
cord-285428-fcrunf38	33	38	fatal	fatal	JJ
cord-285428-fcrunf38	33	39	COVID-19	covid-19	NN
cord-285428-fcrunf38	33	40	.	.	.
cord-285428-fcrunf38	34	1	This	this	DT
cord-285428-fcrunf38	34	2	latter	latter	JJ
cord-285428-fcrunf38	34	3	group	group	NN
cord-285428-fcrunf38	34	4	can	can	MD
cord-285428-fcrunf38	34	5	be	be	VB
cord-285428-fcrunf38	34	6	well	well	RB
cord-285428-fcrunf38	34	7	identified	identify	VBN
cord-285428-fcrunf38	34	8	by	by	IN
cord-285428-fcrunf38	34	9	carefully	carefully	RB
cord-285428-fcrunf38	34	10	designed	design	VBN
cord-285428-fcrunf38	34	11	epidemiological	epidemiological	JJ
cord-285428-fcrunf38	34	12	studies	study	NNS
cord-285428-fcrunf38	34	13	.	.	.
cord-285428-fcrunf38	35	1	Potential	potential	JJ
cord-285428-fcrunf38	35	2	products	product	NNS
cord-285428-fcrunf38	35	3	must	must	MD
cord-285428-fcrunf38	35	4	demonstrate	demonstrate	VB
cord-285428-fcrunf38	35	5	protection	protection	NN
cord-285428-fcrunf38	35	6	in	in	IN
cord-285428-fcrunf38	35	7	animal	animal	NN
cord-285428-fcrunf38	35	8	models	model	NNS
cord-285428-fcrunf38	35	9	and	and	CC
cord-285428-fcrunf38	35	10	in	in	IN
cord-285428-fcrunf38	35	11	small	small	JJ
cord-285428-fcrunf38	35	12	clinical	clinical	JJ
cord-285428-fcrunf38	35	13	trials	trial	NNS
cord-285428-fcrunf38	35	14	.	.	.
cord-285428-fcrunf38	36	1	To	to	TO
cord-285428-fcrunf38	36	2	avoid	avoid	VB
cord-285428-fcrunf38	36	3	possible	possible	JJ
cord-285428-fcrunf38	36	4	enhancement	enhancement	NN
cord-285428-fcrunf38	36	5	of	of	IN
cord-285428-fcrunf38	36	6	COVID-19	COVID-19	NNP
cord-285428-fcrunf38	36	7	,	,	,
cord-285428-fcrunf38	36	8	antibodies	antibody	NNS
cord-285428-fcrunf38	36	9	might	may	MD
cord-285428-fcrunf38	36	10	be	be	VB
cord-285428-fcrunf38	36	11	given	give	VBN
cord-285428-fcrunf38	36	12	to	to	TO
cord-285428-fcrunf38	36	13	prevent	prevent	VB
cord-285428-fcrunf38	36	14	SARS	SARS	NNP
cord-285428-fcrunf38	36	15	-	-	HYPH
cord-285428-fcrunf38	36	16	CoV-2	CoV-2	NNP
cord-285428-fcrunf38	36	17	infections	infection	NNS
cord-285428-fcrunf38	36	18	after	after	IN
cord-285428-fcrunf38	36	19	the	the	DT
cord-285428-fcrunf38	36	20	removal	removal	NN
cord-285428-fcrunf38	36	21	or	or	CC
cord-285428-fcrunf38	36	22	inactivation	inactivation	NN
cord-285428-fcrunf38	36	23	of	of	IN
cord-285428-fcrunf38	36	24	the	the	DT
cord-285428-fcrunf38	36	25	IgG	IgG	NNP
cord-285428-fcrunf38	36	26	Fc	Fc	NNP
cord-285428-fcrunf38	36	27	terminus	terminus	NN
cord-285428-fcrunf38	36	28	.	.	.
cord-285428-fcrunf38	37	1	9	9	LS
cord-285428-fcrunf38	37	2	Immunoprotection	Immunoprotection	NNP
cord-285428-fcrunf38	37	3	is	be	VBZ
cord-285428-fcrunf38	37	4	an	an	DT
cord-285428-fcrunf38	37	5	especially	especially	RB
cord-285428-fcrunf38	37	6	forceful	forceful	JJ
cord-285428-fcrunf38	37	7	solution	solution	NN
cord-285428-fcrunf38	37	8	that	that	WDT
cord-285428-fcrunf38	37	9	could	could	MD
cord-285428-fcrunf38	37	10	be	be	VB
cord-285428-fcrunf38	37	11	available	available	JJ
cord-285428-fcrunf38	37	12	soon	soon	RB
cord-285428-fcrunf38	37	13	.	.	.
cord-285428-fcrunf38	38	1	Efforts	effort	NNS
cord-285428-fcrunf38	38	2	are	be	VBP
cord-285428-fcrunf38	38	3	well	well	RB
cord-285428-fcrunf38	38	4	underway	underway	JJ
cord-285428-fcrunf38	38	5	by	by	IN
cord-285428-fcrunf38	38	6	many	many	JJ
cord-285428-fcrunf38	38	7	groups	group	NNS
cord-285428-fcrunf38	38	8	to	to	TO
cord-285428-fcrunf38	38	9	derive	derive	VB
cord-285428-fcrunf38	38	10	monoclonal	monoclonal	JJ
cord-285428-fcrunf38	38	11	antibodies	antibody	NNS
cord-285428-fcrunf38	38	12	or	or	CC
cord-285428-fcrunf38	38	13	manufacture	manufacture	VB
cord-285428-fcrunf38	38	14	gamma	gamma	NN
cord-285428-fcrunf38	38	15	globulin	globulin	NN
cord-285428-fcrunf38	38	16	from	from	IN
cord-285428-fcrunf38	38	17	the	the	DT
cord-285428-fcrunf38	38	18	huge	huge	JJ
cord-285428-fcrunf38	38	19	cohort	cohort	NN
cord-285428-fcrunf38	38	20	of	of	IN
cord-285428-fcrunf38	38	21	COVID-19	COVID-19	NNP
cord-285428-fcrunf38	38	22	convalescent	convalescent	JJ
cord-285428-fcrunf38	38	23	immunes	immune	NNS
cord-285428-fcrunf38	38	24	.	.	.
cord-285428-fcrunf38	39	1	3	3	CD
cord-285428-fcrunf38	39	2	,	,	,
cord-285428-fcrunf38	39	3	10	10	CD
cord-285428-fcrunf38	39	4	Moving	move	VBG
cord-285428-fcrunf38	39	5	new	new	JJ
cord-285428-fcrunf38	39	6	products	product	NNS
cord-285428-fcrunf38	39	7	on	on	IN
cord-285428-fcrunf38	39	8	line	line	NN
cord-285428-fcrunf38	39	9	for	for	IN
cord-285428-fcrunf38	39	10	early	early	JJ
cord-285428-fcrunf38	39	11	and	and	CC
cord-285428-fcrunf38	39	12	effective	effective	JJ
cord-285428-fcrunf38	39	13	use	use	NN
cord-285428-fcrunf38	39	14	requires	require	VBZ
cord-285428-fcrunf38	39	15	commitment	commitment	NN
cord-285428-fcrunf38	39	16	and	and	CC
cord-285428-fcrunf38	39	17	leadership	leadership	NN
cord-285428-fcrunf38	39	18	.	.	.
cord-285428-fcrunf38	40	1	As	as	IN
cord-285428-fcrunf38	40	2	suggested	suggest	VBN
cord-285428-fcrunf38	40	3	by	by	IN
cord-285428-fcrunf38	40	4	Safi	Safi	NNP
cord-285428-fcrunf38	40	5	Bahcall	Bahcall	NNP
cord-285428-fcrunf38	41	1	(	(	-LRB-
cord-285428-fcrunf38	41	2	Wall	Wall	NNP
cord-285428-fcrunf38	41	3	Street	Street	NNP
cord-285428-fcrunf38	41	4	Journal	Journal	NNP
cord-285428-fcrunf38	41	5	,	,	,
cord-285428-fcrunf38	41	6	March	March	NNP
cord-285428-fcrunf38	41	7	21	21	CD
cord-285428-fcrunf38	41	8	,	,	,
cord-285428-fcrunf38	41	9	2020	2020	CD
cord-285428-fcrunf38	41	10	)	)	-RRB-
cord-285428-fcrunf38	41	11	,	,	,
cord-285428-fcrunf38	41	12	a	a	DT
cord-285428-fcrunf38	41	13	national	national	JJ
cord-285428-fcrunf38	41	14	science	science	NN
cord-285428-fcrunf38	41	15	leader	leader	NN
cord-285428-fcrunf38	41	16	should	should	MD
cord-285428-fcrunf38	41	17	immediately	immediately	RB
cord-285428-fcrunf38	41	18	be	be	VB
cord-285428-fcrunf38	41	19	appointed	appoint	VBN
cord-285428-fcrunf38	41	20	to	to	TO
cord-285428-fcrunf38	41	21	organize	organize	VB
cord-285428-fcrunf38	41	22	an	an	DT
cord-285428-fcrunf38	41	23	initial	initial	JJ
cord-285428-fcrunf38	41	24	intervention	intervention	NN
cord-285428-fcrunf38	41	25	,	,	,
cord-285428-fcrunf38	41	26	the	the	DT
cord-285428-fcrunf38	41	27	direct	direct	JJ
cord-285428-fcrunf38	41	28	immune	immune	JJ
cord-285428-fcrunf38	41	29	protection	protection	NN
cord-285428-fcrunf38	41	30	of	of	IN
cord-285428-fcrunf38	41	31	at	at	IN
cord-285428-fcrunf38	41	32	-	-	HYPH
cord-285428-fcrunf38	41	33	risk	risk	NN
cord-285428-fcrunf38	41	34	persons	person	NNS
cord-285428-fcrunf38	41	35	at	at	IN
cord-285428-fcrunf38	41	36	industrial	industrial	JJ
cord-285428-fcrunf38	41	37	scale	scale	NN
cord-285428-fcrunf38	41	38	.	.	.
cord-285428-fcrunf38	42	1	Immune	immune	JJ
cord-285428-fcrunf38	42	2	responses	response	NNS
cord-285428-fcrunf38	42	3	in	in	IN
cord-285428-fcrunf38	42	4	COVID-19	covid-19	JJ
cord-285428-fcrunf38	42	5	and	and	CC
cord-285428-fcrunf38	42	6	potential	potential	JJ
cord-285428-fcrunf38	42	7	vaccines	vaccine	NNS
cord-285428-fcrunf38	42	8	:	:	:
cord-285428-fcrunf38	42	9	lessons	lesson	NNS
cord-285428-fcrunf38	42	10	learned	learn	VBN
cord-285428-fcrunf38	42	11	from	from	IN
cord-285428-fcrunf38	42	12	SARS	SARS	NNP
cord-285428-fcrunf38	42	13	and	and	CC
cord-285428-fcrunf38	42	14	MERS	MERS	NNP
cord-285428-fcrunf38	42	15	epidemic	epidemic	NN
cord-285428-fcrunf38	42	16	Prophylactic	prophylactic	JJ
cord-285428-fcrunf38	42	17	and	and	CC
cord-285428-fcrunf38	42	18	therapeutic	therapeutic	JJ
cord-285428-fcrunf38	42	19	remdesivir	remdesivir	NNS
cord-285428-fcrunf38	42	20	(	(	-LRB-
cord-285428-fcrunf38	42	21	GS-5734	GS-5734	NNP
cord-285428-fcrunf38	42	22	)	)	-RRB-
cord-285428-fcrunf38	42	23	treatment	treatment	NN
cord-285428-fcrunf38	42	24	in	in	IN
cord-285428-fcrunf38	42	25	the	the	DT
cord-285428-fcrunf38	42	26	rhesus	rhesus	NNP
cord-285428-fcrunf38	42	27	macaque	macaque	NN
cord-285428-fcrunf38	42	28	model	model	NN
cord-285428-fcrunf38	42	29	of	of	IN
cord-285428-fcrunf38	42	30	MERS	MERS	NNP
cord-285428-fcrunf38	42	31	-	-	HYPH
cord-285428-fcrunf38	42	32	CoV	CoV	NNP
cord-285428-fcrunf38	42	33	infection	infection	NN
cord-285428-fcrunf38	43	1	The	the	DT
cord-285428-fcrunf38	43	2	convalescent	convalescent	JJ
cord-285428-fcrunf38	43	3	sera	sera	NN
cord-285428-fcrunf38	43	4	option	option	NN
cord-285428-fcrunf38	43	5	for	for	IN
cord-285428-fcrunf38	43	6	containing	contain	VBG
cord-285428-fcrunf38	43	7	COVID-19	COVID-19	.
cord-285428-fcrunf38	43	8	The	the	DT
cord-285428-fcrunf38	43	9	effectiveness	effectiveness	NN
cord-285428-fcrunf38	43	10	of	of	IN
cord-285428-fcrunf38	43	11	convalescent	convalescent	JJ
cord-285428-fcrunf38	43	12	plasma	plasma	NN
cord-285428-fcrunf38	43	13	and	and	CC
cord-285428-fcrunf38	43	14	hyperimmune	hyperimmune	NNP
cord-285428-fcrunf38	43	15	immunoglobulin	immunoglobulin	NN
cord-285428-fcrunf38	43	16	for	for	IN
cord-285428-fcrunf38	43	17	the	the	DT
cord-285428-fcrunf38	43	18	treatment	treatment	NN
cord-285428-fcrunf38	43	19	of	of	IN
cord-285428-fcrunf38	43	20	severe	severe	JJ
cord-285428-fcrunf38	43	21	acute	acute	JJ
cord-285428-fcrunf38	43	22	respiratory	respiratory	JJ
cord-285428-fcrunf38	43	23	infections	infection	NNS
cord-285428-fcrunf38	43	24	of	of	IN
cord-285428-fcrunf38	43	25	viral	viral	JJ
cord-285428-fcrunf38	43	26	etiology	etiology	NN
cord-285428-fcrunf38	43	27	:	:	:
cord-285428-fcrunf38	43	28	a	a	DT
cord-285428-fcrunf38	43	29	systematic	systematic	JJ
cord-285428-fcrunf38	43	30	review	review	NN
cord-285428-fcrunf38	43	31	and	and	CC
cord-285428-fcrunf38	43	32	exploratory	exploratory	JJ
cord-285428-fcrunf38	43	33	meta	meta	JJ
cord-285428-fcrunf38	43	34	-	-	HYPH
cord-285428-fcrunf38	43	35	analysis	analysis	NN
cord-285428-fcrunf38	43	36	Postexposure	Postexposure	NNP
cord-285428-fcrunf38	43	37	passive	passive	JJ
cord-285428-fcrunf38	43	38	immunisation	immunisation	NN
cord-285428-fcrunf38	43	39	for	for	IN
cord-285428-fcrunf38	43	40	preventing	prevent	VBG
cord-285428-fcrunf38	43	41	measles	measle	NNS
cord-285428-fcrunf38	43	42	Use	Use	NNP
cord-285428-fcrunf38	43	43	of	of	IN
cord-285428-fcrunf38	43	44	concentrated	concentrated	JJ
cord-285428-fcrunf38	43	45	human	human	JJ
cord-285428-fcrunf38	43	46	serum	serum	NN
cord-285428-fcrunf38	43	47	gammaglobulin	gammaglobulin	NN
cord-285428-fcrunf38	43	48	in	in	IN
cord-285428-fcrunf38	43	49	the	the	DT
cord-285428-fcrunf38	43	50	prevention	prevention	NN
cord-285428-fcrunf38	43	51	and	and	CC
cord-285428-fcrunf38	43	52	attenuation	attenuation	NN
cord-285428-fcrunf38	43	53	of	of	IN
cord-285428-fcrunf38	43	54	measles	measle	NNS
cord-285428-fcrunf38	43	55	Passive	passive	JJ
cord-285428-fcrunf38	43	56	immunization	immunization	NN
cord-285428-fcrunf38	43	57	against	against	IN
cord-285428-fcrunf38	43	58	poliomyelitis	poliomyelitis	NN
cord-285428-fcrunf38	43	59	:	:	:
cord-285428-fcrunf38	43	60	the	the	DT
cord-285428-fcrunf38	43	61	Hammon	Hammon	NNP
cord-285428-fcrunf38	43	62	gamma	gamma	NN
cord-285428-fcrunf38	43	63	globulin	globulin	NN
cord-285428-fcrunf38	43	64	field	field	NN
cord-285428-fcrunf38	43	65	trials	trial	NNS
cord-285428-fcrunf38	43	66	Infectious	infectious	JJ
cord-285428-fcrunf38	43	67	hepatitis	hepatitis	NN
cord-285428-fcrunf38	43	68	:	:	:
cord-285428-fcrunf38	43	69	current	current	JJ
cord-285428-fcrunf38	43	70	status	status	NN
cord-285428-fcrunf38	43	71	of	of	IN
cord-285428-fcrunf38	43	72	prevention	prevention	NN
cord-285428-fcrunf38	43	73	with	with	IN
cord-285428-fcrunf38	43	74	gamma	gamma	NNP
cord-285428-fcrunf38	43	75	globulin	globulin	NNP
cord-285428-fcrunf38	43	76	Molecular	Molecular	NNP
cord-285428-fcrunf38	43	77	mechanism	mechanism	NN
cord-285428-fcrunf38	43	78	for	for	IN
cord-285428-fcrunf38	43	79	antibody	antibody	NN
cord-285428-fcrunf38	43	80	-	-	HYPH
cord-285428-fcrunf38	43	81	dependent	dependent	JJ
cord-285428-fcrunf38	43	82	enhancement	enhancement	NN
cord-285428-fcrunf38	43	83	of	of	IN
cord-285428-fcrunf38	43	84	coronavirus	coronavirus	NN
cord-285428-fcrunf38	43	85	entry	entry	NN
cord-285428-fcrunf38	43	86	Perspectives	perspective	NNS
cord-285428-fcrunf38	43	87	on	on	IN
cord-285428-fcrunf38	43	88	monoclonal	monoclonal	JJ
cord-285428-fcrunf38	43	89	antibody	antibody	NN
cord-285428-fcrunf38	43	90	therapy	therapy	NN
cord-285428-fcrunf38	43	91	as	as	IN
cord-285428-fcrunf38	43	92	potential	potential	JJ
cord-285428-fcrunf38	43	93	therapeutic	therapeutic	JJ
cord-285428-fcrunf38	43	94	intervention	intervention	NN
cord-285428-fcrunf38	43	95	for	for	IN
cord-285428-fcrunf38	43	96	Coronavirus	Coronavirus	NNP
cord-285428-fcrunf38	43	97	disease-19	disease-19	,
cord-285428-fcrunf38	43	98	(	(	-LRB-
cord-285428-fcrunf38	43	99	COVID-19	COVID-19	NNP
cord-285428-fcrunf38	43	100	)	)	-RRB-